Abbott Labs to cut 1,200 jobs

A new entrant into the layoff club is Abbott Laboratories, which says it's cutting 1,200 jobs in Ireland and California. Some 500 workers will be laid off from a stent-making factory in Galway, Ireland. Another 700 jobs will be cut from a facility in Temecula, California.  Abbott employs about 65,000 people worldwide, so these layoffs represent less than 2 percent of its workforce. The company plans to take a charge against fourth-quarter earnings for the cuts.

The layoff announcement met with consternation in Ireland, where Abbott now employs about 3,400. Closing the Galway plant will have "major consequences" for the economy there, officials said, calling the layoffs there a "cruel blow." Some politicians called for the Irish government to invest in the Galway region to counteract the effects of the cuts; others want the government to reverse business-tax increases so that Ireland can attract more foreign investment.

- take a look at the report from the Chicago Tribune
- read this account of the local layoffs in The Irish Times

Related Articles:
Panel gives cautious OK to Abbott stent. Report
GE negotiating for Abbott diagnostics unit. Report
J&J sues Abbott to block new stent. Report
Top 5 layoffs of 2007. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.